MMED logo

MMED MiniMed Group, Inc. Common Stock

NASDAQ Global Select · Medical - Equipment & Services · Healthcare

$20.15
+0.13 (+0.65%)

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are c…

Market Cap: $5.66Bwww.minimed.com

Price

No data yet.

Signal Score (90d)

100
100
Aug 17Aug 17

Quote

Day Range
$19.52 – $20.25
52-Week Range
$10.65 – $20.88
Volume
$104.9K
Market Cap
$5.60B
50-Day Avg
$16.33
200-Day Avg
$14.89
Prev Close
$20.15
Open
$20.14

Valuation & Ratios

P/E Ratio
-10.23
EPS
$-1.29
P/B Ratio
0.94
P/S Ratio
1.09
Debt/Equity
0.04
Current Ratio
1.92
Dividend Yield
+0.0%
Gross Margin
+54.2%

Returns & Efficiency

Return on Equity
-9.2%
Return on Assets
-7.1%
FCF Yield
-12.4%
EV/EBITDA
66.00

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$3.10B$-331.00M$-1.29
2024$2.71B$-250.00M$-0.89
2023$2.47B$-112.00M$-0.40
2022$2.25B$-96.00M$-0.34

Social Signal Score

50
5d
51
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Earnings

Tue, Sep 1(in 2 weeks)

Consensus estimate $0.09 per share

0of 2 quarters beat consensus

Typical surprise -256.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Wed, Jun 3$-0.68 vs $-0.15miss
  • Fri, Apr 17$-0.10 vs $0.17miss

Estimates and results for MMED via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Insider trading

Open-market buys and sells by MMED officers and directors.

No open-market trades in the recent filings. All 65 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.

65 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.

Valuation

MMEDhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsprnewswire.com·5h ago·Neutral

    MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor MiniMed Flex™ with Instinct, made by Abbott, combines discreet design, up to 15 days of sensor wear and proven automation to reduce the work and interruptions of diabetes management NORTHRIDGE, Calif., Aug. 17, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED) today announced that the MiniMed Flex™ system is now commercially shipping in the U.S. with the Instinct sensor, made by Abbott.

    View source ↗